Review



m smegmatis  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC m smegmatis
    Screening of the anti-mycobacterial activity of throat swab-derived microbial culture supernatants from TB close contacts. (A) Effects of pooled throat swab-derived microbial culture supernatants on the in vitro growth of BCG. (B) Effects of culture supernatants derived from 12 individual participants on the in vitro growth of BCG. The red boxes highlight samples 5 and 11, which showed the most prominent inhibitory activity against BCG growth among all 12 individuals tested. (C) Representative colony images showing the inhibitory effects of culture supernatants from different individuals on BCG growth. (D-F) PMA-differentiated THP-1 macrophages were infected with BCG (D), H37Rv (E), or M. <t>smegmatis</t> (F), and treated with culture supernatants at the indicated concentrations; intracellular viable bacterial loads were then measured. For the H37Rv infection shown in (E), the 50% supernatant concentration was not tested owing to limited volume of the pooled supernatant. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01; ****, P<0.0001; ns, not significant. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit; TB, tuberculosis.
    M Smegmatis, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 213 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/m+marinum/Mycobacterium+marinum+Aronson/pmc13655852-56-18-20
    Average 96 stars, based on 213 article reviews
    m smegmatis - by Bioz Stars, 2026-11
    96/100 stars

    Images

    1) Product Images from "Upper respiratory tract commensal Streptococcus oralis inhibits mycobacterial growth by producing bioactive molecules and inducing macrophage autophagy"

    Article Title: Upper respiratory tract commensal Streptococcus oralis inhibits mycobacterial growth by producing bioactive molecules and inducing macrophage autophagy

    Journal: Journal of Thoracic Disease

    doi: 10.21037/jtd-2026-2039

    Screening of the anti-mycobacterial activity of throat swab-derived microbial culture supernatants from TB close contacts. (A) Effects of pooled throat swab-derived microbial culture supernatants on the in vitro growth of BCG. (B) Effects of culture supernatants derived from 12 individual participants on the in vitro growth of BCG. The red boxes highlight samples 5 and 11, which showed the most prominent inhibitory activity against BCG growth among all 12 individuals tested. (C) Representative colony images showing the inhibitory effects of culture supernatants from different individuals on BCG growth. (D-F) PMA-differentiated THP-1 macrophages were infected with BCG (D), H37Rv (E), or M. smegmatis (F), and treated with culture supernatants at the indicated concentrations; intracellular viable bacterial loads were then measured. For the H37Rv infection shown in (E), the 50% supernatant concentration was not tested owing to limited volume of the pooled supernatant. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01; ****, P<0.0001; ns, not significant. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit; TB, tuberculosis.
    Figure Legend Snippet: Screening of the anti-mycobacterial activity of throat swab-derived microbial culture supernatants from TB close contacts. (A) Effects of pooled throat swab-derived microbial culture supernatants on the in vitro growth of BCG. (B) Effects of culture supernatants derived from 12 individual participants on the in vitro growth of BCG. The red boxes highlight samples 5 and 11, which showed the most prominent inhibitory activity against BCG growth among all 12 individuals tested. (C) Representative colony images showing the inhibitory effects of culture supernatants from different individuals on BCG growth. (D-F) PMA-differentiated THP-1 macrophages were infected with BCG (D), H37Rv (E), or M. smegmatis (F), and treated with culture supernatants at the indicated concentrations; intracellular viable bacterial loads were then measured. For the H37Rv infection shown in (E), the 50% supernatant concentration was not tested owing to limited volume of the pooled supernatant. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01; ****, P<0.0001; ns, not significant. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit; TB, tuberculosis.

    Techniques Used: Screening, Activity Assay, Derivative Assay, In Vitro, Infection, Concentration Assay, Standard Deviation

    Isolation, identification, and anti-mycobacterial activity validation of a functional S. oralis strain. (A) Effects of candidate functional strain culture supernatants on the in vitro growth of BCG. (B) Effects of culture supernatants from monoclonal isolates obtained from sample 11 on the in vitro growth of BCG; the red box indicates strain 11-9, which was selected for subsequent experiments. (C-E) Changes in viable intracellular H37Rv, BCG, and M. smegmatis burdens in THP-1-derived macrophages after treatment with the culture supernatant of strain 11-9. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit.
    Figure Legend Snippet: Isolation, identification, and anti-mycobacterial activity validation of a functional S. oralis strain. (A) Effects of candidate functional strain culture supernatants on the in vitro growth of BCG. (B) Effects of culture supernatants from monoclonal isolates obtained from sample 11 on the in vitro growth of BCG; the red box indicates strain 11-9, which was selected for subsequent experiments. (C-E) Changes in viable intracellular H37Rv, BCG, and M. smegmatis burdens in THP-1-derived macrophages after treatment with the culture supernatant of strain 11-9. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit.

    Techniques Used: Isolation, Activity Assay, Biomarker Discovery, Functional Assay, In Vitro, Derivative Assay, Standard Deviation

    Preliminary physicochemical characterization of anti-mycobacterial active components in S. oralis culture supernatant. (A,B) Effects of ethanol precipitation fractions on the in vitro growth of BCG and M. smegmatis . (C,D) Effects of different ethanol-precipitated fractions on viable intracellular BCG and M. smegmatis burdens in THP-1-derived macrophages. (E) Effects of culture supernatant on in vitro BCG growth after proteinase K treatment or heat-inactivated proteinase K control treatment. (F) Effects of culture supernatant on viable intracellular BCG burden in THP-1-derived macrophages after proteinase K treatment or heat-inactivated proteinase K control treatment. Results are expressed as the CFU index and presented as the mean ± standard deviation; *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001; ns, not significant. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit.
    Figure Legend Snippet: Preliminary physicochemical characterization of anti-mycobacterial active components in S. oralis culture supernatant. (A,B) Effects of ethanol precipitation fractions on the in vitro growth of BCG and M. smegmatis . (C,D) Effects of different ethanol-precipitated fractions on viable intracellular BCG and M. smegmatis burdens in THP-1-derived macrophages. (E) Effects of culture supernatant on in vitro BCG growth after proteinase K treatment or heat-inactivated proteinase K control treatment. (F) Effects of culture supernatant on viable intracellular BCG burden in THP-1-derived macrophages after proteinase K treatment or heat-inactivated proteinase K control treatment. Results are expressed as the CFU index and presented as the mean ± standard deviation; *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001; ns, not significant. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit.

    Techniques Used: Ethanol Precipitation, In Vitro, Derivative Assay, Control, Standard Deviation

    In vivo antibacterial activity of S. oralis culture supernatant in mouse surrogate mycobacterial infection models. (A) Schematic workflow of the acute M. smegmatis infection model. C57BL/6 mice received culture supernatant from strain 11-9 by oral gavage, were infected intravenously with M. smegmatis , and were assessed for lung bacterial burden at the experimental endpoint. (B) Viable M. smegmatis burdens in lung tissue from each group. (C) Schematic workflow of the systemic BCG infection model. Mice were intravenously infected with BCG, treated by oral gavage with culture supernatant from strain 11-9 beginning on day 3 after infection, and assessed for tissue bacterial burden at the experimental endpoint. (D,E) Viable BCG burdens in the lungs and spleens of mice in each group. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit.
    Figure Legend Snippet: In vivo antibacterial activity of S. oralis culture supernatant in mouse surrogate mycobacterial infection models. (A) Schematic workflow of the acute M. smegmatis infection model. C57BL/6 mice received culture supernatant from strain 11-9 by oral gavage, were infected intravenously with M. smegmatis , and were assessed for lung bacterial burden at the experimental endpoint. (B) Viable M. smegmatis burdens in lung tissue from each group. (C) Schematic workflow of the systemic BCG infection model. Mice were intravenously infected with BCG, treated by oral gavage with culture supernatant from strain 11-9 beginning on day 3 after infection, and assessed for tissue bacterial burden at the experimental endpoint. (D,E) Viable BCG burdens in the lungs and spleens of mice in each group. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit.

    Techniques Used: In Vivo, Activity Assay, Infection, Tissue, Standard Deviation

    Related Articles

    Expressing:

    Article Title: Computational and Experimental Characterization of Mycobacterium marinum β-Carbonic Anhydrase Inhibitors
    Article Snippet: .. A bioluminescence-cassette ( pMV306hsp + LuxG13 ) expressing M marinum (ATCC 927, Mmr) strain was used for the inhibition studies. .. The pMV306hsp + LuxG13 plasmid was a kind gift from Brian Robertson and Siouxsie Wiles (Addgene plasmid #26161; http://n2t.net/addgene:26161 ; RRID: Addgene_26161).

    Inhibition:

    Article Title: Computational and Experimental Characterization of Mycobacterium marinum β-Carbonic Anhydrase Inhibitors
    Article Snippet: .. A bioluminescence-cassette ( pMV306hsp + LuxG13 ) expressing M marinum (ATCC 927, Mmr) strain was used for the inhibition studies. .. The pMV306hsp + LuxG13 plasmid was a kind gift from Brian Robertson and Siouxsie Wiles (Addgene plasmid #26161; http://n2t.net/addgene:26161 ; RRID: Addgene_26161).

    other:


    Infection:

    Article Title: Metabolic Changes in Zebrafish Larvae Infected with Mycobacterium marinum: A Widely Targeted Metabolomic Analysis
    Article Snippet: .. Zebrafish embryos were infected with M. marinum (ATCC BAA-535) at 3 days postfertilization (3 dpf) via microinjection into the duct of Cuvier, with an infection dose of 250 CFU. ..

    Article Title: Metabolic Changes in Zebrafish Larvae Infected with Mycobacterium marinum : A Widely Targeted Metabolomic Analysis
    Article Snippet: .. Zebrafish embryos were infected with M. marinum (ATCC BAA-535) at 3 days post-fertilization (3 dpf) via microinjection into the duct of Cuvier, with an infection dose of 250 CFU. ..

    Microinjection:

    Article Title: Metabolic Changes in Zebrafish Larvae Infected with Mycobacterium marinum: A Widely Targeted Metabolomic Analysis
    Article Snippet: .. Zebrafish embryos were infected with M. marinum (ATCC BAA-535) at 3 days postfertilization (3 dpf) via microinjection into the duct of Cuvier, with an infection dose of 250 CFU. ..

    Article Title: Metabolic Changes in Zebrafish Larvae Infected with Mycobacterium marinum : A Widely Targeted Metabolomic Analysis
    Article Snippet: .. Zebrafish embryos were infected with M. marinum (ATCC BAA-535) at 3 days post-fertilization (3 dpf) via microinjection into the duct of Cuvier, with an infection dose of 250 CFU. ..

    Virus:

    Article Title: Mechanistic evaluation of Clerodendrum serratum anti-biofilm potency against Mycobacterium species.
    Article Snippet: Biofilm formation in Mycobacterium species significantly contributes to their pathogenicity and resistance to conventional antimicrobial therapies, posing a major challenge in clinical management.. Plant-derived phytoconstituents have emerged as promising alternatives due to their diverse biological activities, including antibiofilm properties.. Clerodendrum serratum, a medicinal plant known for antimicrobial potential, offers a rich source of such bioactive compounds.

    Diagnostic Assay:

    Article Title: Mechanistic evaluation of Clerodendrum serratum anti-biofilm potency against Mycobacterium species.
    Article Snippet: Biofilm formation in Mycobacterium species significantly contributes to their pathogenicity and resistance to conventional antimicrobial therapies, posing a major challenge in clinical management.. Plant-derived phytoconstituents have emerged as promising alternatives due to their diverse biological activities, including antibiofilm properties.. Clerodendrum serratum, a medicinal plant known for antimicrobial potential, offers a rich source of such bioactive compounds.

    Amplification:

    Article Title: An unusual genetic switch controls Mycobacterium avium pathogenesis, antibiotic resistance and colony morphology
    Article Snippet: For construction of complementation plasmids, erp, marP, and recA were PCR amplified with PrimeStar GXL polymerase (Takara) from the genomic DNA of mc 2 2500. .. Msm erp, Mmar erp, Mab erp, and Mtb erp were amplified by standard PCR from the genomic DNA of M. smegmatis (mc 2 155), M. marinum (ATCC 927), M. abcessus (ATCC 19977), and M. tuberculosis (Erdman (ATCC 35801), respectively, including native upstream and downstream regulatory elements. .. Mlep erp (AL450380.1) was ordered as a synthetic gene block from Integrated DNA Technologies.

    Polymerase Chain Reaction:

    Article Title: An unusual genetic switch controls Mycobacterium avium pathogenesis, antibiotic resistance and colony morphology
    Article Snippet: For construction of complementation plasmids, erp, marP, and recA were PCR amplified with PrimeStar GXL polymerase (Takara) from the genomic DNA of mc 2 2500. .. Msm erp, Mmar erp, Mab erp, and Mtb erp were amplified by standard PCR from the genomic DNA of M. smegmatis (mc 2 155), M. marinum (ATCC 927), M. abcessus (ATCC 19977), and M. tuberculosis (Erdman (ATCC 35801), respectively, including native upstream and downstream regulatory elements. .. Mlep erp (AL450380.1) was ordered as a synthetic gene block from Integrated DNA Technologies.



    Similar Products

    96
    ATCC m smegmatis
    Screening of the anti-mycobacterial activity of throat swab-derived microbial culture supernatants from TB close contacts. (A) Effects of pooled throat swab-derived microbial culture supernatants on the in vitro growth of BCG. (B) Effects of culture supernatants derived from 12 individual participants on the in vitro growth of BCG. The red boxes highlight samples 5 and 11, which showed the most prominent inhibitory activity against BCG growth among all 12 individuals tested. (C) Representative colony images showing the inhibitory effects of culture supernatants from different individuals on BCG growth. (D-F) PMA-differentiated THP-1 macrophages were infected with BCG (D), H37Rv (E), or M. <t>smegmatis</t> (F), and treated with culture supernatants at the indicated concentrations; intracellular viable bacterial loads were then measured. For the H37Rv infection shown in (E), the 50% supernatant concentration was not tested owing to limited volume of the pooled supernatant. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01; ****, P<0.0001; ns, not significant. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit; TB, tuberculosis.
    M Smegmatis, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/m+marinum/Mycobacterium+marinum+Aronson/pmc13655852-56-18-20
    Average 96 stars, based on 1 article reviews
    m smegmatis - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    ATCC mycobacterium marinum m strain
    Screening of the anti-mycobacterial activity of throat swab-derived microbial culture supernatants from TB close contacts. (A) Effects of pooled throat swab-derived microbial culture supernatants on the in vitro growth of BCG. (B) Effects of culture supernatants derived from 12 individual participants on the in vitro growth of BCG. The red boxes highlight samples 5 and 11, which showed the most prominent inhibitory activity against BCG growth among all 12 individuals tested. (C) Representative colony images showing the inhibitory effects of culture supernatants from different individuals on BCG growth. (D-F) PMA-differentiated THP-1 macrophages were infected with BCG (D), H37Rv (E), or M. <t>smegmatis</t> (F), and treated with culture supernatants at the indicated concentrations; intracellular viable bacterial loads were then measured. For the H37Rv infection shown in (E), the 50% supernatant concentration was not tested owing to limited volume of the pooled supernatant. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01; ****, P<0.0001; ns, not significant. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit; TB, tuberculosis.
    Mycobacterium Marinum M Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/m+marinum/Mycobacterium+marinum+Aronson/pm42070669-42-1-5
    Average 96 stars, based on 1 article reviews
    mycobacterium marinum m strain - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    ATCC m marinum m
    Screening of the anti-mycobacterial activity of throat swab-derived microbial culture supernatants from TB close contacts. (A) Effects of pooled throat swab-derived microbial culture supernatants on the in vitro growth of BCG. (B) Effects of culture supernatants derived from 12 individual participants on the in vitro growth of BCG. The red boxes highlight samples 5 and 11, which showed the most prominent inhibitory activity against BCG growth among all 12 individuals tested. (C) Representative colony images showing the inhibitory effects of culture supernatants from different individuals on BCG growth. (D-F) PMA-differentiated THP-1 macrophages were infected with BCG (D), H37Rv (E), or M. <t>smegmatis</t> (F), and treated with culture supernatants at the indicated concentrations; intracellular viable bacterial loads were then measured. For the H37Rv infection shown in (E), the 50% supernatant concentration was not tested owing to limited volume of the pooled supernatant. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01; ****, P<0.0001; ns, not significant. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit; TB, tuberculosis.
    M Marinum M, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/m+marinum/Mycobacterium+marinum+Aronson/pm42017691-183-7-10
    Average 96 stars, based on 1 article reviews
    m marinum m - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    DSMZ m marinum dsmz 44344 sgm fish pathogenic m mucogenicum dsmz 44124 rgm
    Screening of the anti-mycobacterial activity of throat swab-derived microbial culture supernatants from TB close contacts. (A) Effects of pooled throat swab-derived microbial culture supernatants on the in vitro growth of BCG. (B) Effects of culture supernatants derived from 12 individual participants on the in vitro growth of BCG. The red boxes highlight samples 5 and 11, which showed the most prominent inhibitory activity against BCG growth among all 12 individuals tested. (C) Representative colony images showing the inhibitory effects of culture supernatants from different individuals on BCG growth. (D-F) PMA-differentiated THP-1 macrophages were infected with BCG (D), H37Rv (E), or M. <t>smegmatis</t> (F), and treated with culture supernatants at the indicated concentrations; intracellular viable bacterial loads were then measured. For the H37Rv infection shown in (E), the 50% supernatant concentration was not tested owing to limited volume of the pooled supernatant. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01; ****, P<0.0001; ns, not significant. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit; TB, tuberculosis.
    M Marinum Dsmz 44344 Sgm Fish Pathogenic M Mucogenicum Dsmz 44124 Rgm, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/m+marinum/Mycobacterium+mucogenicum/pm41797401-44-73-75
    Average 94 stars, based on 1 article reviews
    m marinum dsmz 44344 sgm fish pathogenic m mucogenicum dsmz 44124 rgm - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    98
    ATCC m marinum
    <t>Inhibition</t> of M <t>marinum</t> in culture by the identified compounds and/or rifampicin. Panel A shows the growth inhibition of M marinum by compound F10111367, while Panel B depicts its effect in combination with rifampicin. Panel C illustrates the inhibition of M marinum by compound F26860257, and Panel D shows the synergistic effect when F26860257 is combined with rifampicin. Growth inhibition was evaluated across multiple compound concentrations over time; MIC values were not formally determined.
    M Marinum, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/m+marinum/Pen-Strep/pmc12949308-130-8-10
    Average 98 stars, based on 1 article reviews
    m marinum - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    96
    ATCC m marinum m strain
    <t>Inhibition</t> of M <t>marinum</t> in culture by the identified compounds and/or rifampicin. Panel A shows the growth inhibition of M marinum by compound F10111367, while Panel B depicts its effect in combination with rifampicin. Panel C illustrates the inhibition of M marinum by compound F26860257, and Panel D shows the synergistic effect when F26860257 is combined with rifampicin. Growth inhibition was evaluated across multiple compound concentrations over time; MIC values were not formally determined.
    M Marinum M Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/m+marinum/Mycobacterium+marinum+Aronson/bio_rxiv__64898__2026__02__06__702658-144-0-4
    Average 96 stars, based on 1 article reviews
    m marinum m strain - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    95
    ATCC m marinum atcc baa
    <t>Inhibition</t> of M <t>marinum</t> in culture by the identified compounds and/or rifampicin. Panel A shows the growth inhibition of M marinum by compound F10111367, while Panel B depicts its effect in combination with rifampicin. Panel C illustrates the inhibition of M marinum by compound F26860257, and Panel D shows the synergistic effect when F26860257 is combined with rifampicin. Growth inhibition was evaluated across multiple compound concentrations over time; MIC values were not formally determined.
    M Marinum Atcc Baa, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/m+marinum/Mycobacterium+marinum/pm41494963-24-4-6
    Average 95 stars, based on 1 article reviews
    m marinum atcc baa - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    Image Search Results


    Screening of the anti-mycobacterial activity of throat swab-derived microbial culture supernatants from TB close contacts. (A) Effects of pooled throat swab-derived microbial culture supernatants on the in vitro growth of BCG. (B) Effects of culture supernatants derived from 12 individual participants on the in vitro growth of BCG. The red boxes highlight samples 5 and 11, which showed the most prominent inhibitory activity against BCG growth among all 12 individuals tested. (C) Representative colony images showing the inhibitory effects of culture supernatants from different individuals on BCG growth. (D-F) PMA-differentiated THP-1 macrophages were infected with BCG (D), H37Rv (E), or M. smegmatis (F), and treated with culture supernatants at the indicated concentrations; intracellular viable bacterial loads were then measured. For the H37Rv infection shown in (E), the 50% supernatant concentration was not tested owing to limited volume of the pooled supernatant. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01; ****, P<0.0001; ns, not significant. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit; TB, tuberculosis.

    Journal: Journal of Thoracic Disease

    Article Title: Upper respiratory tract commensal Streptococcus oralis inhibits mycobacterial growth by producing bioactive molecules and inducing macrophage autophagy

    doi: 10.21037/jtd-2026-2039

    Figure Lengend Snippet: Screening of the anti-mycobacterial activity of throat swab-derived microbial culture supernatants from TB close contacts. (A) Effects of pooled throat swab-derived microbial culture supernatants on the in vitro growth of BCG. (B) Effects of culture supernatants derived from 12 individual participants on the in vitro growth of BCG. The red boxes highlight samples 5 and 11, which showed the most prominent inhibitory activity against BCG growth among all 12 individuals tested. (C) Representative colony images showing the inhibitory effects of culture supernatants from different individuals on BCG growth. (D-F) PMA-differentiated THP-1 macrophages were infected with BCG (D), H37Rv (E), or M. smegmatis (F), and treated with culture supernatants at the indicated concentrations; intracellular viable bacterial loads were then measured. For the H37Rv infection shown in (E), the 50% supernatant concentration was not tested owing to limited volume of the pooled supernatant. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01; ****, P<0.0001; ns, not significant. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit; TB, tuberculosis.

    Article Snippet: The Mtb reference strain H37Rv (ATCC 27294), the attenuated Mycobacterium bovis Bacillus Calmette-Guérin (BCG) strain (ATCC 35733), and M. smegmatis (ATCC BAA-535) were maintained in our laboratory.

    Techniques: Screening, Activity Assay, Derivative Assay, In Vitro, Infection, Concentration Assay, Standard Deviation

    Isolation, identification, and anti-mycobacterial activity validation of a functional S. oralis strain. (A) Effects of candidate functional strain culture supernatants on the in vitro growth of BCG. (B) Effects of culture supernatants from monoclonal isolates obtained from sample 11 on the in vitro growth of BCG; the red box indicates strain 11-9, which was selected for subsequent experiments. (C-E) Changes in viable intracellular H37Rv, BCG, and M. smegmatis burdens in THP-1-derived macrophages after treatment with the culture supernatant of strain 11-9. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit.

    Journal: Journal of Thoracic Disease

    Article Title: Upper respiratory tract commensal Streptococcus oralis inhibits mycobacterial growth by producing bioactive molecules and inducing macrophage autophagy

    doi: 10.21037/jtd-2026-2039

    Figure Lengend Snippet: Isolation, identification, and anti-mycobacterial activity validation of a functional S. oralis strain. (A) Effects of candidate functional strain culture supernatants on the in vitro growth of BCG. (B) Effects of culture supernatants from monoclonal isolates obtained from sample 11 on the in vitro growth of BCG; the red box indicates strain 11-9, which was selected for subsequent experiments. (C-E) Changes in viable intracellular H37Rv, BCG, and M. smegmatis burdens in THP-1-derived macrophages after treatment with the culture supernatant of strain 11-9. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit.

    Article Snippet: The Mtb reference strain H37Rv (ATCC 27294), the attenuated Mycobacterium bovis Bacillus Calmette-Guérin (BCG) strain (ATCC 35733), and M. smegmatis (ATCC BAA-535) were maintained in our laboratory.

    Techniques: Isolation, Activity Assay, Biomarker Discovery, Functional Assay, In Vitro, Derivative Assay, Standard Deviation

    Preliminary physicochemical characterization of anti-mycobacterial active components in S. oralis culture supernatant. (A,B) Effects of ethanol precipitation fractions on the in vitro growth of BCG and M. smegmatis . (C,D) Effects of different ethanol-precipitated fractions on viable intracellular BCG and M. smegmatis burdens in THP-1-derived macrophages. (E) Effects of culture supernatant on in vitro BCG growth after proteinase K treatment or heat-inactivated proteinase K control treatment. (F) Effects of culture supernatant on viable intracellular BCG burden in THP-1-derived macrophages after proteinase K treatment or heat-inactivated proteinase K control treatment. Results are expressed as the CFU index and presented as the mean ± standard deviation; *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001; ns, not significant. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit.

    Journal: Journal of Thoracic Disease

    Article Title: Upper respiratory tract commensal Streptococcus oralis inhibits mycobacterial growth by producing bioactive molecules and inducing macrophage autophagy

    doi: 10.21037/jtd-2026-2039

    Figure Lengend Snippet: Preliminary physicochemical characterization of anti-mycobacterial active components in S. oralis culture supernatant. (A,B) Effects of ethanol precipitation fractions on the in vitro growth of BCG and M. smegmatis . (C,D) Effects of different ethanol-precipitated fractions on viable intracellular BCG and M. smegmatis burdens in THP-1-derived macrophages. (E) Effects of culture supernatant on in vitro BCG growth after proteinase K treatment or heat-inactivated proteinase K control treatment. (F) Effects of culture supernatant on viable intracellular BCG burden in THP-1-derived macrophages after proteinase K treatment or heat-inactivated proteinase K control treatment. Results are expressed as the CFU index and presented as the mean ± standard deviation; *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001; ns, not significant. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit.

    Article Snippet: The Mtb reference strain H37Rv (ATCC 27294), the attenuated Mycobacterium bovis Bacillus Calmette-Guérin (BCG) strain (ATCC 35733), and M. smegmatis (ATCC BAA-535) were maintained in our laboratory.

    Techniques: Ethanol Precipitation, In Vitro, Derivative Assay, Control, Standard Deviation

    In vivo antibacterial activity of S. oralis culture supernatant in mouse surrogate mycobacterial infection models. (A) Schematic workflow of the acute M. smegmatis infection model. C57BL/6 mice received culture supernatant from strain 11-9 by oral gavage, were infected intravenously with M. smegmatis , and were assessed for lung bacterial burden at the experimental endpoint. (B) Viable M. smegmatis burdens in lung tissue from each group. (C) Schematic workflow of the systemic BCG infection model. Mice were intravenously infected with BCG, treated by oral gavage with culture supernatant from strain 11-9 beginning on day 3 after infection, and assessed for tissue bacterial burden at the experimental endpoint. (D,E) Viable BCG burdens in the lungs and spleens of mice in each group. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit.

    Journal: Journal of Thoracic Disease

    Article Title: Upper respiratory tract commensal Streptococcus oralis inhibits mycobacterial growth by producing bioactive molecules and inducing macrophage autophagy

    doi: 10.21037/jtd-2026-2039

    Figure Lengend Snippet: In vivo antibacterial activity of S. oralis culture supernatant in mouse surrogate mycobacterial infection models. (A) Schematic workflow of the acute M. smegmatis infection model. C57BL/6 mice received culture supernatant from strain 11-9 by oral gavage, were infected intravenously with M. smegmatis , and were assessed for lung bacterial burden at the experimental endpoint. (B) Viable M. smegmatis burdens in lung tissue from each group. (C) Schematic workflow of the systemic BCG infection model. Mice were intravenously infected with BCG, treated by oral gavage with culture supernatant from strain 11-9 beginning on day 3 after infection, and assessed for tissue bacterial burden at the experimental endpoint. (D,E) Viable BCG burdens in the lungs and spleens of mice in each group. Results are expressed as the CFU index and presented as the mean ± standard deviation. *, P<0.05; **, P<0.01. BCG, Bacillus Calmette-Guérin; CFU, colony-forming unit.

    Article Snippet: The Mtb reference strain H37Rv (ATCC 27294), the attenuated Mycobacterium bovis Bacillus Calmette-Guérin (BCG) strain (ATCC 35733), and M. smegmatis (ATCC BAA-535) were maintained in our laboratory.

    Techniques: In Vivo, Activity Assay, Infection, Tissue, Standard Deviation

    Inhibition of M marinum in culture by the identified compounds and/or rifampicin. Panel A shows the growth inhibition of M marinum by compound F10111367, while Panel B depicts its effect in combination with rifampicin. Panel C illustrates the inhibition of M marinum by compound F26860257, and Panel D shows the synergistic effect when F26860257 is combined with rifampicin. Growth inhibition was evaluated across multiple compound concentrations over time; MIC values were not formally determined.

    Journal: Bioinformatics and Biology Insights

    Article Title: Computational and Experimental Characterization of Mycobacterium marinum β-Carbonic Anhydrase Inhibitors

    doi: 10.1177/11779322261427120

    Figure Lengend Snippet: Inhibition of M marinum in culture by the identified compounds and/or rifampicin. Panel A shows the growth inhibition of M marinum by compound F10111367, while Panel B depicts its effect in combination with rifampicin. Panel C illustrates the inhibition of M marinum by compound F26860257, and Panel D shows the synergistic effect when F26860257 is combined with rifampicin. Growth inhibition was evaluated across multiple compound concentrations over time; MIC values were not formally determined.

    Article Snippet: A bioluminescence-cassette ( pMV306hsp + LuxG13 ) expressing M marinum (ATCC 927, Mmr) strain was used for the inhibition studies.

    Techniques: Inhibition